VOLUME 59   1998   SUPPLEMENT 15

Articles

3 Introduction. Optimizing Clinical Use of SSRIs: Theory and Practice. Alexander H. Glassman, M.D.
[PDF]

4 Brain Serotonin Neurotransmission: An Overview and Update With an Emphasis on Serotonin Subsystem Heterogeneity, Multiple Receptors, Interactions With Other Neurotransmitter Systems, and Consequent Implications for Understanding the Actions of Serotonergic Drugs. Dennis L. Murphy, M.D.; Anne M. Andrews, Ph.D.; Christine H. Wichems, Ph.D.; Qian Li, Ph.D.; Michihisa Tohda, Ph.D.; and Benjamin Greenberg, M.D., Ph.D.
[Abstract] [PDF]

13 Cardiovascular Effects of Antidepressant Drugs: Updated. Alexander H. Glassman, M.D.
[Abstract] [PDF]

19 Drug Interactions With Newer Antidepressants: Role of Human Cytochromes P450. David J. Greenblatt, M.D.; Lisa L. von Moltke, M.D.; Jerold S. Harmatz; and Richard I. Shader, M.D.
[Abstract] [PDF]

28 The Use of Selective Serotonin Reuptake Inhibitors in Eating Disorders. Laurel E. S. Mayer, M.D., and B. Timothy Walsh, M.D.
[Abstract] [PDF]

35 Treatment of Antidepressant Nonresponders: Augmentation or Switch? J. Craig Nelson, M.D.
[Abstract] [PDF]

42 SSRI Safety in Overdose. Jean T. Barbey, M.D., and Steven P. Roose, M.D.
[Abstract] [PDF]